TRENSUS-PHARM 100

Description

TRENSUS-PHARM 100 (Trenbolone Injection 100 mg/1.5 ml) is an Injectable preparation for IM administration containing un-esterfied Trenbolone in a water base. Each 1.5 ml contains Trenbolone 100 mg.

Pharmacodynamics

Trenbolone is a derivative of Nandrolone, in that it lacks the methyl group at position 19. Trenbolone binds strongly to both the androgen receptor and the progesterone receptor. This strong binding likely makes Trenbolone an agonist of the progesterone receptor. Though people generally believe progesterone agonists cause gynecomastia, progesterone agonists actually result in the down regulation of estrogen receptors. As mentioned, Trenbolone binds strongly to the androgen receptor (stronger than any commercially available androgen) and is not metabolized to 3-alpha metabolites in skeletal muscle delivering rapid strength and size gains.

Indications and Usage

Trenbolone is indicated for increasing muscular mass, hardness without water retention and now estrogenic activity, as well as increasing the metabolic rate, which means an increase of the fat burning rate.

Dosage and Administration

100 to 200mg weekly through IM administration.

Adverse effects

Side effects include high blood pressure, acne and hair loss among others. This steroid also has a reputation for being toxic to the kidneys. There is no direct evidence for this side effect in the scientific literature but since the kidneys do respond to androgenic stimulation and Trenbolone can cause hypertension, which can also damage the kidneys, care should be taken.

Overdose

None

Storage

Store in cool dry place below 25°C. Protect from light.

Packing

5 ampoules are packed in a plastic tray.

Marketed by

MJ Pharma